Univariate analysis revealed that patients expressing high levels of DCLK1 in their colon cancer tissues had a significantly (p < 0.01) worse prognosis than patients with low DCLK1 expression in their cancer tissues (Figure 7C). This evidence concerns the gene DCLK1 and malignant colon neoplasm.